» Authors » D V Durand

D V Durand

Explore the profile of D V Durand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 199
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Josserand R, Bey-Omar F, ROLLET J, Lejeune H, Boggio D, Durand D, et al.
Hum Reprod . 2001 Sep; 16(10):2093-7. PMID: 11574497
Background: Most infertile males with congenital bilateral absence of vas deferens (CBAVD) carry mutations on the cystic fibrosis transmembrane conductance regulator gene and may express mild cystic fibrosis (CF) symptoms....
2.
Sibille M, Durieu I, Durand D
N Engl J Med . 2000 Sep; 343(9):662; author reply 663. PMID: 10979807
No abstract available.
3.
Durieu I, Durupt S, Josserand R, Durand D, Bey-Omar F
Scand J Gastroenterol . 2000 Jan; 34(12):1260. PMID: 10636077
No abstract available.
4.
Zenone T, Felman P, Malcus C, Durieu I, Durand D
Am J Med . 1999 Nov; 107(5):509-11. PMID: 10569307
No abstract available.
5.
Durupt S, Durieu I, David G, Zenone T, Nove-Josserand R, LEVRAT R, et al.
Rev Med Interne . 1999 Jul; 20 Suppl 2:304s-305s. PMID: 10422180
No abstract available.
6.
Zenone T, Grange C, Pelissier P, Zabot M, Plauchu H, Durand D, et al.
Rev Med Interne . 1999 Jul; 20(6):538-9. PMID: 10422149
No abstract available.
7.
Durieu I, Pellet O, Simonot L, Durupt S, Bellon G, Durand D, et al.
J Hepatol . 1999 Jul; 30(6):1052-6. PMID: 10406183
Background/aims: Liver disease is a leading cause of morbidity in adult patients with cystic fibrosis. Diagnosis of limited liver involvement in asymptomatic patients is important since a safe and effective...
8.
Murat G, Bernon H, Zenone T, Durand D, Bienvenu J
Ann Biol Clin (Paris) . 1999 Apr; 57(2):218-20. PMID: 10210750
No abstract available.
9.
Sibille M, Deigat N, Durieu I, Guillaumont M, Morel D, Bienvenu J, et al.
Eur J Clin Pharmacol . 1999 Apr; 55(1):13-9. PMID: 10206079
Objective: Laboratory data are key evaluation procedures for Phase I clinical pharmacology for two reasons. Firstly, laboratory data are used within the screening process to exclude subjects with asymptomatic diseases,...
10.
Durieu I, Peyrol S, Gindre D, Bellon G, Durand D, Pacheco Y
Am J Respir Crit Care Med . 1998 Aug; 158(2):580-8. PMID: 9700138
Cystic fibrosis is a genetic disease caused by mutations of the cystic fibrosis transmembrane conductance regulator gene. Chronic inflammation and proteolysis lead to progressive damage of the bronchial wall. Extracellular...